These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 629497)

  • 21. Dialysis treatment of psoriasis.
    Anderson PC
    Arch Dermatol; 1981 Feb; 117(2):67-8. PubMed ID: 7469442
    [No Abstract]   [Full Text] [Related]  

  • 22. Continuous ambulatory peritoneal dialysis for psoriasis.
    Twardowski ZJ; Anderson PC
    Mo Med; 1985 Jan; 82(1):15-7. PubMed ID: 3969062
    [No Abstract]   [Full Text] [Related]  

  • 23. The activity of polymorphonuclear leukocyte neutral proteinases and their inhibitors in patients with psoriasis treated with a continuous peritoneal dialysis.
    Glinski W; Zarebska Z; Jabłonska S; Imiela J; Nosarzewski J
    J Invest Dermatol; 1980 Dec; 75(6):481-7. PubMed ID: 6777433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remission of psoriasis during haemodialysis.
    Muston HL; Conceicao S
    Br Med J; 1978 Feb; 1(6111):480-1. PubMed ID: 626844
    [No Abstract]   [Full Text] [Related]  

  • 25. Dialysis and psoriasis.
    Rapaport M
    J Am Acad Dermatol; 1983 Mar; 8(3):426-7. PubMed ID: 6833547
    [No Abstract]   [Full Text] [Related]  

  • 26. [Persistent psoriasis: failure of PUVA and peritoneal dialysis-response to methotrexate and hydroxyurea].
    de Bast C; Oleffe J; De Coninck A; Van Opdenbosch L
    Dermatologica; 1982 Nov; 165(5):450-3. PubMed ID: 7169117
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful treatment with ustekinumab of psoriasis vulgaris in a patient undergoing hemodialysis.
    Nimmannitya K; Tateishi C; Mizukami Y; Hamamoto K; Yamada S; Goto H; Okada S; Tsuruta D
    J Dermatol; 2016 Jan; 43(1):92-4. PubMed ID: 26103788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clearing of psoriasis after cardiac surgery requiring cardiopulmonary bypass oxygenation: a corollary to clearance after dialysis?
    Buselmeier TJ; Cantieri JS; Dahl MV; Nelson RS; Baumgaertner JC; Bentley CR; Goltz RW
    Br J Dermatol; 1979 Mar; 100(3):311-3. PubMed ID: 435390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dialysis for psoriasis.
    Rose I
    Can Med Assoc J; 1979 May; 120(10):1209, 1212-3. PubMed ID: 445263
    [No Abstract]   [Full Text] [Related]  

  • 30. Dialysis for psoriasis.
    Buselmeier TJ
    JAMA; 1979 Dec; 242(23):2557. PubMed ID: 490874
    [No Abstract]   [Full Text] [Related]  

  • 31. [Myoneuropathy in patients with chronic renal failure treated with hemodialysis (HD) and intermittent peritoneal dialysis (IPD). II. Sensory and motor nerve conduction velocity in patients with chronic renal failure treated with intermittent peritoneal dialysis and hemodialysis].
    Wanic-Kossowska M; Koczocik-Przedpelska J
    Pol Arch Med Wewn; 1996 Mar; 95(3):237-44. PubMed ID: 8755854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage migration inhibitory activity in the sera of patients undergoing peritoneal dialysis for psoriasis.
    Halevy S; Halevy J; Livni E; Boner G; Rosenfeld JB; Feuerman EJ
    Arch Dermatol Res; 1982; 274(1-2):73-8. PubMed ID: 6762162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneal dialysis is associated with better cognitive function than hemodialysis over a one-year course.
    Neumann D; Mau W; Wienke A; Girndt M
    Kidney Int; 2018 Feb; 93(2):430-438. PubMed ID: 29042081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In search of "psoriasis factor(s)": a new approach by extracorporeal treatment.
    Chen WT; Hu CH; Schiltz JR; Nakamoto S
    Artif Organs; 1978 May; 2(2):203-5. PubMed ID: 687178
    [No Abstract]   [Full Text] [Related]  

  • 35. Continuous peritoneal dialysis for treatment of psoriasis. II. Destruction of stratum corneum with peritoneal PMNL serine proteinase.
    Gliński W; Jabłońska S; Jarzabek-Chorzelska M; Zarebska Z; Imiela J; Nosarzewski J
    Arch Dermatol Res; 1979 Aug; 266(1):83-6. PubMed ID: 507932
    [No Abstract]   [Full Text] [Related]  

  • 36. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanding indications for dialysis.
    Port FK
    Int J Artif Organs; 1979 Mar; 2(2):47-8. PubMed ID: 468392
    [No Abstract]   [Full Text] [Related]  

  • 38. Hemodialysis therapy for psoriasis.
    Chugh KS; Kumar B; Pareek SK; Kher V; Singhal PC; Lal M; Sharma L
    Artif Organs; 1982 Feb; 6(1):9-12. PubMed ID: 7073529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis.
    Rubin HR; Fink NE; Plantinga LC; Sadler JH; Kliger AS; Powe NR
    JAMA; 2004 Feb; 291(6):697-703. PubMed ID: 14871912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Amino acid loss and protein spectrum of the peritoneal dialysate during continuous peritoneal dialysis].
    Günther K; Feist H; Lang H; Sperschneider H; Fünfstück R; Stein G
    Z Urol Nephrol; 1983 Dec; 76(12):795-800. PubMed ID: 6670385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.